Clinical Trials in Salt Lake City

Showing 9281-9300 of 16,694 trials

Anti-SEMA4D Monoclonal Antibody VX15/2503 With Nivolumab or Ipilimumab in Treating Patients With Stage III or IV Melanoma

NCT03425461

This randomized pilot phase I trial studies the side effects and best dose of anti-SEMA4D monoclonal antibody VX15/2503 when given together with nivolumab or ipilimumab in treating patients with stage III or IV melanoma. Monoclonal antibodies, such as anti-SEMA4D monoclonal antibody VX15/2503, nivolumab, and ipilimumab, may interfere with the ability of tumor cells to grow and spread.

Metastatic MelanomaStage III Cutaneous Melanoma AJCC v7Stage IIIA Cutaneous Melanoma AJCC v7+3 more

Jonsson Comprehensive Cancer Center6 participantsStarted Jun 2018

Los Angeles, California, United States • Salt Lake City, Utah, United States

TERMINATEDPhase 3< 1 mile

Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis

NCT03398837

This is a Phase 3 multicenter, double-blind, randomized, placebo-controlled study assessing the efficacy and safety of lenabasum for the treatment of diffuse cutaneous systemic sclerosis (SSc). Approximately 354 subjects will be enrolled in this study at about 60 sites in North America, Europe, Australia, and Asia. The planned duration of treatment with study drug is 52 weeks.

Diffuse Cutaneous Systemic Sclerosis

Corbus Pharmaceuticals Inc.365 participantsStarted Dec 2017

La Jolla, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +71 more locations

Anti-SEMA4D Monoclonal Antibody VX15/2503 With Nivolumab or Ipilimumab in Treating Patients With Stage III or IV Melanoma

Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis

Find Trials by Condition in Salt Lake City

GLORIA-AF Registry Program - Second and Third Phases

Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads

Reverse Shoulder Prosthesis Prospective Multi-Center Study

Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab

Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use"

Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone

A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression

Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)

Norketotifen for the Treatment of Uncomplicated Influenza-like Illness

Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)

Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia

Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer

A Study Evaluating the Safety and Pharmacokinetics of ABBV-744 in Participants With Relapsed/Refractory Acute Myeloid Leukemia (AML) Cancer

An Open-label Study to Evaluate Correct Use and Ease of Use of the ELLIPTA DPI in Pediatric Subjects With Asthma

Clinical Study to Compare 3 Multi-Layered Foam Dressings for the Management of Chronic Wounds

Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-REDUCED)

HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM

American Trial Using Tranexamic Acid in Thrombocytopenia